Bio-Imaging looks to expand oncology imaging technology
This article was originally published in Clinica
Executive Summary
Bio-Imaging Technologies has signed a sponsorship agreement worth around $3 million to develop its oncology imaging technology. Phase I and II clinical trials costing more than $1 million for the company will be followed by Phase III/IV post-approval trials in early 1997.